The molecular mechanisms involved in luteolysis are still unclear in the primate. This study aimed to investigate the effect of induced luteolysis on the ovarian luteinizing hormone (LH) receptor and the steroidogenic enzyme, 3β-hydroxysteroid dehydrogenase (3β-HSD) in the marmoset monkey. Luteolysis was induced in the mid-luteal phase either directly by systemic prostaglandin F 2α (PGF 2α ), or indirectly by LH withdrawal using systemic gonadotrophin releasing hormone antagonist (GnRH ant ) treatment. The LH receptor was studied by isotopic mRNA in-situ hybridization and in-situ ligand binding and 3β-HSD expression was studied using isotopic mRNA in-situ hybridization and immunohistochemistry. Induced luteolysis was associated with a reduction in the expression of LH receptor (P < 0.0001) and 3β-HSD mRNA, closely followed by a reduction in the LH receptor (P < 0.05) and 3β-HSD protein concentrations within 24 h. There were no differences in the findings whether luteolysis was induced with PGF 2α or GnRH ant . This study shows that disparate mechanisms to induce luteolysis in the primate result in an identical rapid loss of the LH receptor and 3β-HSD. In conclusion, induced luteolysis leads to rapid loss of the steroidogenic pathway in luteal cells. Key words: corpus luteum/3β-hydroxysteroid dehydrogenase/ immunohistochemistry/in-situ hybridization/luteinizing hormone receptor
Introduction
The molecular mechanisms of luteolysis in the primate and of how the functional and structural integrity of the corpus luteum are lost, are still unclear (Auletta and Flint, 1988; Behrman et al., 1993) . It has recently been shown that cell death by apoptosis (Juengel et al., 1993; Fraser et al., 1995a; Young et al., 1997) and remodelling of the extracellular matrix by matrix metalloproteinase enzymes , are likely to contribute to the loss of the structural integrity of the corpus luteum during luteolysis. The molecular mechanisms responsible for the loss of its functional integrity and its falling progesterone output, however, are still not fully understood.
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The primate corpus luteum is dependent on the trophic support of luteinizing hormone (LH) from the pituitary gland. LH binds specifically to the LH receptor, a seven transmembrane region G-protein-coupled receptor (Segaloff and Ascoli, 1993) on the surface of luteal cells, to stimulate steroidogenic enzymes to produce progesterone. Withdrawal of LH results in luteolysis (Fraser et al., 1986) , whereas human chorionic gonadotrophin (HCG), from the implanting blastocyst, acts through the LH receptor to maintain steroidogenesis and 'rescue' the corpus luteum. We have previously shown that during luteal 'rescue', the LH receptor is maintained and is not down-regulated by its ligand (Duncan et al., 1996a) .
There is a significant reduction in luteal LH receptors preceded by reduced receptor mRNA concentrations after prostaglandin F 2α (PGF 2α )-induced luteolysis in ruminants (Guy et al., 1995; Smith et al., 1996) . This is thought to contribute to the functional decline of the ruminant corpus luteum. However, in the monkey, LH receptor mRNA increased during the late-luteal phase (Ravindranath et al., 1992a) when progesterone output declined. Similarly, in the human, LH receptor mRNA and binding activity can be detected in the late-luteal corpus luteum (Nishimori et al., 1995; Duncan et al., 1996a) , but not in the corpus luteum after menstruation (Ravindranath et al., 1992a; Nishimori et al., 1995) . In the primate, functional luteolysis is thought to occur initially in the presence of normal concentrations of LH receptors.
The primate corpus luteum is capable of recovering from a transient withdrawal of gonadotrophic support (Hutchison and Zeleznik, 1985) but not from natural functional luteolysis (Stouffer et al., 1977) . This study investigated the effect of coordinated induced luteolysis on LH receptor and 3β-hydroxysteroid dehydrogenase (3β-HSD) expression in the primate. The marmoset monkey was used, as luteolysis can be induced by systemic PGF 2α , although uterine PGF 2α is not the natural luteolysin in this species. In addition, luteolysis can be induced by LH withdrawal using gonadotrophin releasing hormone antagonist (GnRH ant ). We aimed to discover whether PGF 2α had the same effect on luteal LH receptors in the primate as the ruminant, and whether induced luteolysis by withdrawal of gonadotrophic support had the same effect.
Materials and methods

Collection of tissue
Captive-bred common marmoset monkeys (Callithrix jacchus jacchus) were maintained in a colony which has been closed since 1973. All experiments were carried out in accordance with the Animals (Scientific Procedures) Act 1986. To confirm normal ovulatory cycles, plasma samples were collected by femoral venepuncture on alternate days Figure 1 . Luteinizing hormone (LH) receptor in the mid-luteal marmoset corpus luteum: (a) dark-field in-situ hybridization of LH receptor mRNA in the control mid-luteal corpus luteum (CL), no signal is seen in the stroma and tiny follicles (F); (b) light-field section of (a), showing the position of the corpus luteum (CL), stroma and tiny follicles (F); (c) dark-field serial negative control section of (a) using the sense probe for LH receptor mRNA, no signal can be seen in the corpus luteum (CL) or the tiny follicles (F); (d) light field higher power (scale bar ϭ 25 µm) section of corpus luteum showing silver grains in steroidogenic cells (S) but not in endothelial-like cells (E); (e) darkfield serial section of (a) after LH binding studies showing binding over the corpus luteum (CL) and not over the stroma and tiny follicles (F). Scale bar ϭ 200 µm.
and stored at -20°C until required. These samples were assayed for progesterone to determine the date of ovulation and the luteal phase duration (Smith et al., 1990) . The marmoset normally ovulates two to three follicles and has a functional luteal phase of 18-21 days.
Ovaries were collected on day 10 of the luteal phase as previously described (Fraser et al., 1995a; Duncan et al., 1996b) . Ovaries were collected from untreated control animals (n ϭ 4) and animals treated with: PGF 2α analogue, cloprostenol (1 µg i.m. injection; Planate, Coopers Animal Health Ltd, Crewe, Cheshire, UK), 24 h (n ϭ 4) previously; GnRH ant , antarelix ([N-Ac-D-Nal 1 , D-pCl-Phe 2 , D-Pal 3 , D-(Hic) 6 , Lys(iPr) 8 , D-Ala 10 ]GnRH (Deghenghi et al., 1993) , 500 µg/kg s.c. injection, Europeptides (GEIE), Argenteuil, Val-D'Oise, France), 12 h (n ϭ 2) and 24 h (n ϭ 4) previously. Whole ovaries were snapfrozen in embedding medium (Tissue-Tek OCT compound; Miles Inc., Elkhart, IN, USA) and stored at -70°C until sectioning. Frozen sections (5 µm) were prepared from these ovaries and stored at -70°C until use. In addition, ovaries were also available from control (n ϭ 4) and treated animals (n ϭ 6) which had been fixed in 4% paraformaldehyde for 24 h and embedded in paraffin wax (Fraser et al., 1995a) . Five-micrometer sections were cut onto poly-L-lysine (50 µg/l)-coated slides for immunohistochemical analysis. In-situ hybridization Isotopic in-situ hybridization was performed on frozen sections using S 35 -labelled riboprobes as described previously (Duncan et al., 1996a) . Antisense and sense LH receptor riboprobes incorporating S 35 -labelled UTP (Amersham International plc, Aylesbury, Bucks, UK) were synthesized using a commercial kit (Promega). The antisense probe was generated from the plasmid vector linearized by HindIII using T3 RNA polymerase. The sense probe was used as a negative control. This was generated from the plasmid vector linearized by ECoR1 using T7 RNA polymerase. The antisense riboprobe for 3β-HSD mRNA was generated by T7 RNA polymerase after plasmid linearization by SstI.
Source of reagents
Frozen sections (5 µm) on poly-L-lysine (50 µg/l)-coated slides were quickly thawed and fixed in 4% paraformaldehyde for 5 min at room temperature. After washing in 0.1 M sodium phosphate, slides were rinsed firstly in water and then in 0.1 M triethanolamine (TEA) pH 8. The slides were then acetylated in 0.25% (v/v) acetic anhydride (BDH Laboratory Supplies, Poole, Dorset, UK) in TEA. After acetylation, the slides were washed in 2ϫSSC (1ϫSSC is 150 mM NaCl, 15 mM sodium citrate) pH 7, and dehydrated through graded alcohols. The slides were then dried under vacuum in a desiccator for 1 h at room temperature. An aliquot of 100 µl of hybridization buffer (50% deionized formamide, 10% dextran sulphate, 1ϫDenhardt's solution, 0.5 mg/ml yeast tRNA, 10 mM dithiothreitol (DTT), 0.3 M NaCl, 10 mM Tris, 1 mM EDTA pH 8) containing 1ϫ10 6 c.p.m. radiolabelled probe was added to each section. The slides were covered with a hydrophobic coverslip (Gel Bond; ICN Biomedical Ltd, High Wycombe, Bucks, UK) and incubated overnight at 55°C in a moist chamber.
The following day the coverslips were washed off in 4ϫSSC. After several rinses in 4ϫSSC, the slides were treated with RNase A (20 µg/ml) in RNase buffer (10 mM Tris, 1 mM EDTA, 0.5 M NaCl, pH 8) for 30 min at 37°C. The sections were de-salted by rinsing in 2ϫSSC/1 mM DTT, followed by 1ϫSSC/1 mM DTT and 2534 0.5ϫSSC/1 mM DTT at room temperature. The slides were then washed for 30 min in 0.1ϫSSC at 70°C in a shaking water bath. After rinsing in 0.1ϫSSC/1 mM DTT at room temperature, the sections were dehydrated through graded alcohols containing 1 mM DTT and 0.08ϫSSC, washed in pure ethanol and allowed to dry. These slides were then dipped in photographic emulsion (Kodak NTB-2; IBI Ltd, Cambridge, Cambs, UK) and stored at 4°C for 18 days in the dark. After developing (Kodak D-19) and fixing (Kodak Unifix) at 15°C in the dark, the slides were washed in water, counterstained in haematoxylin, dehydrated through graded alcohols and mounted in Pertex mounting medium (Cellpath, Hemel Hempstead, Herts, UK).
In-situ ligand binding
In-situ ligand binding was performed as described previously (Duncan et al., 1996a) . Frozen sections (5 µm) were quickly thawed and incubated in binding buffer [50 mM HEPES, 5 mM MgCl 2 , 0.3% (w/v) BSA, pH 7.4] at room temperature for 20 min. Excess buffer was removed and 10 000 c.p.m. of iodinated LH or 10 000 c.p.m. iodinated LH with excess (20 IU) of cold HCG (Profasi; Serono Laboratories, Welwyn Garden City, Herts, UK), in binding buffer was added to each slide for 2 h at room temperature. The slides were briefly washed four times in 0.05 M Tris pH 7.4 at 4°C, dipped in distilled water and allowed to dry for 3 h at 4°C. They were then Figure 3 . Luteinizing hormone (LH) receptor in marmoset corpora lutea after induced luteolysis. Grain density of LH receptor mRNA and grain counts of LH receptor binding in marmoset corpora lutea in the mid-luteal phase (control) (n ϭ 4), 12 h after induced luteolysis with GnRH ant (GnRH 12 h) (n ϭ 2), 24 h after induced luteolysis with GnRH ant (GnRH 24 h) (n ϭ 4) and 24 h after induced luteolysis with PGF 2α (PG 24) (n ϭ 4). Values are mean Ϯ SEM; *P Ͻ 0.05, **P Ͻ 0.0001 (ANOVA). dipped in photographic emulsion (Kodak NTB-2) and stored at 4°C for 3 days in the dark. After developing (Kodak D-19) and fixing (Kodak Unifix) at 15°C in the dark, the slides were washed in water, counterstained in haematoxylin, dehydrated through graded alcohols and mounted in Pertex mounting medium.
Immunohistochemistry
Sections were dewaxed in xylene, then rehydrated through graded alcohols to water. Sections then underwent microwave antigen retrieval at full power in four 5 min cycles in 0.01 M sodium citrate, pH 6.0. After standing for 20 min at room temperature, the slides were washed in 0.05 M Tris buffered saline, pH 8.0 (TBS) for 10 min. The sections were then incubated overnight at 4°C with the polyclonal rabbit anti-human 3β-HSD antiserum diluted 1:300 in TBS. On the following day, the sections were washed with TBS and then incubated with biotinylated goat anti-rabbit immunoglobulins (Dako Ltd, High Wycombe, Bucks, UK), diluted 1:500 in 20% normal goat serum (NGS) (SAPU, Carluke, Lanarkshire, UK), 5% BSA in TBS, for 1 h at room temperature. After being washed with TBS, sections were incubated with avidin-biotin alkaline phosphatase complex (Dako Ltd) for 1 h at room temperature, then washed again with TBS and developed with chromagen to give a red end product (Alkaline Phosphatase Substrate Kit I; Vector Laboratories, Peterborough, Cambs, UK). Sections were counterstained with haematoxylin, dehydrated through graded alcohols and cleared in xylene prior to mounting. Polyclonal rabbit IgG (Dako Ltd) at the same antibody concentration was used in place of the primary antibody, in serial sections, as a negative control.
Analysis of sections
The distribution and number of silver grains was analysed by darkfield microscopy after image capture, using computer-based image analysis systems. To quantify the results of the in-situ hybridization, the area proportion of silver grains over the steroidogenic cells was 2535 measured in five random fields for each section using an image analysis program (NIH Image 1.5; NIH Bethseda, MD, USA). Acellular areas or areas without the steroidogenic cells were ignored. Only sections from the same run, performed under carefully controlled conditions, were analysed. The results of the in-situ ligand binding were analysed in a similar fashion except that the grain distribution in this case allowed measurement of absolute numbers of grains. In each case, the grain density was compared in each treatment group using analysis of variance (ANOVA) with a 5% level of significance using a commercial statistics computer program (StatView 4.0; Abacus Concepts Inc., Berkeley, CA, USA).
Results
Progesterone concentrations
As described previously (Duncan et al., 1996b) , progesterone concentrations in the control animals were 330 Ϯ 69 nmol/l (mean Ϯ SEM). Functional luteal regression was observed in all animals treated with either the GnRH antagonist or the prostaglandin analogue (Fraser et al., 1995b) . Prostaglandin treatment resulted in a decline in progesterone concentrations to 22 Ϯ 6 nmol/l after 24 h, and treatment with GnRH antagonist resulted in progesterone concentrations of 13 nmol/ l after 12 h and 23 Ϯ 11 nmol/l after 24 h. All progesterone concentrations after induced luteolysis were within the normal range of follicular phase concentrations in the marmoset (Smith et al., 1990) .
LH receptor after induced luteolysis
Messenger RNA for the LH receptor was detected by in-situ hybridization in corpora lutea of marmoset ovaries from the mid-luteal phase (Figure 1a,b) . No specific signal was present in the negative control sections incubated with the sense riboprobe ( Figure 1c) . LH receptors were localized to individual steroidogenic cells within corpora lutea. No hybridization signal could be seen in cells without the morphological appearance of steroidogenic cells which expressed 3β-HSD, including endothelial cells (Figure 1d ). The localization of LH receptor binding corresponded to the localization of LH receptor mRNA (Figure 1e ). No specific binding was seen in negative control sections where excess cold HCG was added.
Messenger RNA for the LH receptor was also expressed in the theca cell layer of antral follicles in ovarian tissue from the mid-luteal phase (Figure 2a,b) . After induced luteolysis, by PGF 2α or GnRH ant administration, LH receptor mRNA disappeared from corpora lutea but was maintained in the theca cell layer of antral follicles (Figure 2c,d) . Luteal LH receptor mRNA concentrations fell after treatment to very low concentrations 12 and 24 h (P Ͻ 0.0001) after induced luteolysis (Figure 3 ). Luteal LH receptor binding was similar to controls 12 h after induced luteolysis but was significantly reduced by 24 h (P Ͻ 0.05) (Figure 3) . Although the small numbers at 12 h precluded accurate statistical analysis, the loss of LH binding appeared to lag behind the loss of LH receptor mRNA (Figures 3, 4a-f ). There were no differences in luteal LH receptor mRNA or binding where luteolysis was induced with PGF 2α or GnRH ant . ) showing LH binding in the corpus luteum (CL) but not the surrounding stroma (S); (e) dark-field serial section of (b), showing persistence of LH binding in the corpus luteum (CL) and its absence from the surrounding stroma (S); (f) dark-field serial section of (c) showing reduced specific LH binding in the corpus luteum. Scale bar ϭ 100 µm.
3β-HSD after induced luteolysis
Both mRNA (Figure 5a ) and protein (Figure 5b ) for 3β-HSD could be detected in corpora lutea of mid-luteal phase ovaries. Twenty-four hours after induced luteolysis, with either PGF 2α or GnRH ant no mRNA for 3β-HSD could be detected in corpora lutea (Figure 5c ) although it could still be detected in the theca cell layer of developing follicles. 24 h after induced luteolysis, 3β-HSD protein could still be detected by immunohistochemistry (Figure 5d) , however, the immunostaining was more patchy and less intense (Figure 5d ) in each ovary studied.
Discussion
This study reports the expression of the LH receptor and the steroidogenic enzyme 3β-HSD after induced luteolysis in the primate. We have previously reported the expression and localization of the LH receptor in the human corpus luteum throughout the functional luteal phase and during simulated early pregnancy (Duncan et al., 1996a) . In that study, it was not clear that LH receptor mRNA fell during the late-luteal phase. Other studies have suggested either an increase (Ravindranath et al., 1992a) or a fall (Nishimori et al., 1995; Minegishi et al., 1997) in luteal LH receptor mRNA during the late-luteal phase in the primate. We therefore used a well established model (Fraser et al., 1995a,b; Duncan et al., 1996b) of induced luteolysis in the primate in this follow-up study, to investigate the effect of luteolysis of LH receptor expression. It is now clear that induced luteolysis in the primate is associated with a rapid loss of LH receptors from the corpus luteum.
Induced luteolysis has been shown to result in a fall in LH receptor expression in rodents (Bjurulf and Selstam, 1996) and ruminants (Guy et al., 1995; Smith et al., 1996) . In these animals, PGF 2α is an important physiological luteolysin. In Figure 5 . 3β-HSD in the marmoset corpus luteum after induced luteolysis: (a) dark-field section of a mid-luteal marmoset ovary after in-situ hybridization for 3β-HSD mRNA showing signal in the corpus luteum (CL) but not the surrounding stroma (S); (b) section of a mid-luteal marmoset ovary after immunohistochemistry for 3β-HSD showing staining of the corpus luteum (CL) but not the surrounding stroma (S); (c) dark-field section of a marmoset ovary 24 h after luteolysis was induced with PGF 2α after in-situ hybridization for 3β-HSD mRNA showing no signal in the corpus luteum (CL) and stroma (S); (d) section of a marmoset ovary 24 h after luteolysis was induced with PGF 2α after immunohistochemistry for 3β-HSD, showing patchy staining of the corpus luteum (CL) but not the surrounding stroma (S). Scale bar ϭ 100 µm. rats, luteal prostaglandin increases during the last days of the luteal phase (Olofsson et al., 1990) and inhibition of prostaglandin synthesis by indomethacin prolongs the natural life-span of the corpus luteum (Bjurulf et al., 1994) . In sheep and cows, natural luteolysis is clearly attributed to the uterine synthesis and secretion of PGF 2α (Niswender et al., 1985; Auletta and Flint, 1988) . In these species, it is thought that PGF 2α has a direct effect on luteal LH receptor mRNA expression (Bjurulf and Selstam, 1996; Smith et al., 1996) . Although it is not clear in this study whether the reduced LH receptor mRNA is due to decreased transcription or decreased mRNA stability (Segaloff and Ascoli, 1993) , it is clear that, despite different mechanisms of luteolysis in primates (Auletta and Flint, 1988) , the effect of PGF 2α of LH receptor mRNA concentrations appears to be the same.
There is evidence that locally produced PGF 2α may have a role in primate luteolysis (Auletta et al., 1984; Auletta and Flint, 1987; Behrman et al., 1993) . Prostaglandins are produced by the human corpus luteum and PGF 2α receptors can be detected in the human corpus luteum (Challis et al., 1976) . Pharmacological doses of prostaglandins can reduce progesterone secretion from the primate corpus luteum (Wentz and Jones, 1973; Auletta et al., 1984) . In addition, some studies 2537 have reported increased intra-luteal PGF 2α during the end of the functional human luteal phase (Shutt et al., 1976; Patwardhan and Lanthier, 1980) . As LH receptors cannot be detected in follicular phase primate corpora lutea (Ravandranath et al., 1992a; Nishimori et al., 1995; Takao et al., 1997) , it is clear that they disappear with functional luteolysis. Local PGF 2α may be involved in the inhibition of LH receptor expression at the end of the primate luteal phase.
The steroidogenic pathway can also be affected at other sites by PGF 2α . In vitro, PGF 2α inhibits LH-stimulated progesterone production, and this is thought to be a post-cAMP-mediated effect (Auletta and Flint, 1988; Abayasekara et al., 1993; Michael et al., 1994) . PGF 2α is known to activate protein kinase C (PKC) (Niswender et al., 1994) , which has several effects on the steroidogenic pathway. It inhibits cholesterol transport to cytochrome P450 side chain cleavage enzyme (P450 scc ) (Wiltbank et al., 1993) , which suggests an inhibitory effect on sterol carrier protein-2 (SCP-2) (McLean et al., 1995) or steroidogenic acute regulatory protein (StAR) (Stocco and Clark, 1996) . In addition it has been shown that expression of 3β-HSD can also be inhibited in vitro (Hawkens et al., 1993) . We have shown that 3β-HSD mRNA and protein expression are inhibited during PGF 2α -induced luteolysis in the primate. This confirms that the multiple sites of inhibition of steroidogenesis during PGF 2α -induced luteolysis are also seen in the primate.
Induced luteolysis using LH withdrawal had the same effects on luteal LH receptor and 3β-HSD expression. It has previously been shown that removal of LH support in monkeys caused a dramatic down-regulation of mRNA for both P450 scc and 3β-HSD (Ravindranath et al., 1992b) . Indeed, concentrations of 3β-HSD have been shown to decline during natural luteal regression in the primate (Doody et al., 1990) . We have confirmed the fall in 3β-HSD message and shown that this is associated with a fall in LH receptor mRNA. The similarity of the effects of the disparate ways to induce luteolysis in the marmoset suggests common final pathways of action. It is not known whether LH withdrawal induces local PGF 2α formation. However, it has been shown that HCG, acting through the LH receptor, has an inhibitory effect on luteolysis induced by PGF 2α (Auletta and Kelm, 1994) . It is therefore likely that LH withdrawal and PGF 2α activate a common final pathway to induce luteolysis.
That common pathway might be progesterone withdrawal. It is clear that acute administration of PGF 2α can inhibit progesterone synthesis in the absence of changes in the expression of steroidogenic enzymes (Michael et al., 1994) . Its effects on cAMP stimulation and progesterone output precede the observed decrease in mRNA concentrations (Khan and Rosberg, 1979; Bjurulf and Selstam, 1996) . Likewise, withdrawal of LH results in rapid cessation of progesterone output (Fraser et al., 1986) . It is possible that progesterone itself has an autocrine role in the corpus luteum. The primate corpus luteum possesses receptors to the progesterone it produces (Chandrasekher et al., 1994; Suzuki et al., 1994) . Recent work using trilostane to inhibit progesterone synthesis suggests that progesterone may indeed have a major role in the function of the corpus luteum (Duffy et al., 1994; Duffy and Stouffer, 1995) . However, it is not yet clear if progesterone maintains the enzymes responsible for its production. Evidence from the rat, where PGF 2α only induces a transient decline in LH receptor and 3β-HSD mRNA suggests that their recovery occurs in the presence of follicular phase concentrations of progesterone (McLean et al., 1995; Bjurulf and Selstam, 1996) . The fact that we did not see this recovery, and that the rat does not appear to express luteal progesterone receptors (ParkeSarge et al., 1995) suggests that this may be a species effect. Progesterone therefore remains a potential candidate in the control of luteal function during luteolysis.
The effect of induced luteolysis on mRNA was evident before the effect on protein concentrations. We could detect little LH receptor and 3β-HSD mRNA 12 h after induced luteolysis. In sheep, Smith et al. (1996) reported that this reduction was evident within 6 h of induced luteolysis. We found continued LH receptor binding 12 h after induced luteolysis and could detect some 3β-HSD protein 24 h after induced luteolysis in the absence of mRNA. The patchy appearance of 3β-HSD we observed after induced luteolysis is similar to that seen during natural luteolysis in the monkey (Sanders and Stouffer, 1997) . This time difference of effects on mRNA and protein concentrations was also seen in ovine 2538 corpora lutea after induced luteolysis with PGF 2α (Smith et al., 1996) . This is consistent with protein having a longer turnover time than mRNA. However, as progesterone concentrations were at follicular concentrations, 12 h after induced luteolysis, it appears that this protein is not stimulated enough to be functional at this stage. It therefore needs to be stressed that at the first time point studied (12 h), the progesterone concentrations were already at follicular concentrations. It is not clear whether the decline in progesterone precedes the inhibition of LH and 3β-HSD expression, is secondary to it, or related through another common factor. It would be interesting to dissect the pathway at time points earlier than 12 h.
Induced luteolysis in the marmoset monkey is associated with cell death and disruption of the cellular architecture (Fraser et al., 1995a) . Indeed it has been suggested that PGF 2α can directly cause apoptotic cell death (Sawyer et al., 1990) . It is possible that the fall in mRNA and protein for the LH receptor and 3β-HSD reflects a general loss of cell viability within the corpus luteum rather than being specific to functional luteolysis. This is unlikely, as the loss of mRNA clearly precedes the loss of protein for both the LH receptor and 3β-HSD, and other mRNA species are still present in the corpus luteum 12 h after induced luteolysis (Duncan et al., 1996b) . In addition, some proteins have been shown to increase in the corpus luteum after induced luteolysis in the marmoset (Woad et al., 1996) . This suggests that the steroidogenic pathway is specifically and rapidly switched off during induced luteolysis.
The rapid loss of LH receptor mRNA in the corpus luteum was not seen in the thecal layers of antral follicles after induced luteolysis. This LH receptor will be equally starved of its ligand after GnRH ant -induced luteolysis. The inhibitory effects on LH receptor and 3β-HSD mRNA was clearly not seen in the thecal cells. This suggests that the common luteolytic pathway is not found in follicular thecal cells. It is not known whether these cells express PGF 2α receptors. In the sheep corpus luteum, PGF 2α receptors are located on the large luteal cells, and not the small luteal cells, that are thought to be of thecal origin (Fitz et al., 1982) . This may be one of the differences. Thecal cells of the follicle, however, may express progesterone receptors (Suzuki et al., 1994) . Clearly studying the differences between follicular thecal cells and luteal cells may aid understanding of the luteolytic process.
In conclusion, the rapid reduction of LH receptors and the steroidogenic enzyme 3β-HSD during induced luteolysis in the primate suggests an inhibition to synthesis of the components of the steroidogenic pathway as well as their function during luteolysis. It is still not clear if this is a cause or effect of low progesterone concentrations, but it is likely to contribute to the continued inhibition of progesterone synthesis during luteolysis. The similarity of effect of PGF 2α treatment and LH withdrawal, however, suggests a common inhibitory pathway. Dissection of this pathway may give more information about the continuing enigma of primate luteolysis.
